EndoVascular Aortic Repair With Sac Embolization for the Prevention of Type II Endoleaks (the EVAR-SE Study)

Recruiting N/A Interventional Study
Abdominal Aortic Aneurysm Endoleak
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
100 (estimated)
Sponsor
Univ.-Prof. Dr. Dr. med. Daniela Branzan · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Beyond a certain threshold diameter, Abdominal aortic aneurysms (AAA) are treated by open surgical repair or, more often by endovascular aortic aneurysm repair (EVAR). The latter involves implantation of a stent-graft and thereby exclusion of the AAA from the blood circuit. Small vessels supplying parts of the bowel or the spine are regularly covered. In a quarter of patients, this may result in a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Infrarenal AAA ≥50 mm maximum diameter * Indication for EVAR within IFU of company * Presence of one or both high risk criteria on CT-A: ≥5 patent efferent vessels (inferior mesenteric and/or lumbar artery, and/or median sacral artery) or \<40% thrombus at larg…
Contacts

Daniela Branzan, Univ.-Prof. Dr. Dr. med.

0049-894140

gefaesschirurgie@mri.tum.de

CONTACT

Marie Kristin Fritsche, Dr. rer. nat.

0046-894140

evarse.gc@mri.tum.de

CONTACT